Radiofrequency properties of two different Licox® parenchymal brain tissue oxygen probe designs. [PDF]
, 2018 Neuroimaging and continuous multimodality neuromonitoring are both central to the intensive care management of patients with severe traumatic brain injury.
Ercole, Ari
core +1 more source
Urokinase-type plasminogen activator (uPA) regulates invasion and matrix remodelling in colorectal cancer [PDF]
, 2023 Background Cancer cells remodel their local physical environment through processes of matrix reorganisation, deposition, stiffening and degradation.
Cheema, Umber +8 more
core
The use of a uPAR-targeted probe for photothermal cancer therapy prolongs survival in a xenograft mouse model of glioblastoma. [PDF]
Oncotarget, 2021 Simón M +3 more
europepmc +1 more source
Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention. [PDF]
Front Cell Dev Biol, 2021 Leth JM, Ploug M.
europepmc +1 more source
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer. [PDF]
J Transl Med, 2022 Zhai BT +8 more
europepmc +1 more source
Moving from non-emergency bleeps and long-range pagers to a hospital-wide, EHR-integrated secure messaging system: an implementer report. [PDF]
BMJ Health Care Inform, 2023 Ercole A +7 more
europepmc +1 more source
Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights. [PDF]
Cancers (Basel), 2021 Iacobazzi RM +13 more
europepmc +1 more source
Synthesis of new AAZTA bifunctional chelators for the development of innovative PET imaging agents [PDF]
, 2021 Hawala, Ivan, Terreno, Enzo
core
The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities. [PDF]
Cancers (Basel), 2021 Metrangolo V, Ploug M, Engelholm LH.
europepmc +1 more source